Novocuff
PrivateLast Round
Series A
Jul 17, 2024
Total Funding Raised
$26.3M
Company Overview
Novocuff is a medical device company that creates innovative solutions to prevent preterm birth, including a minimally invasive device designed to stabilize the cervix and extend pregnancy duration for both singleton and multiple gestation pregnancies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novocuff Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Novocuff Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 17, 2024 | ||||
| Grant | Aug 10, 2023 |
Novocuff Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| March of Dimes | Series A |
| NIH RADx | Grant |
| Avestria Ventures | Series A |
| RH Capital | Series A |
Novocuff Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novocuff's valuation, stock price, and market status.